CoChat

Semagacestat for Treatment of Alzheimer's Disease

Rachelle S Doody, Paul S. S Aisen, Takeshi Iwatsubo · 2013 · New England Journal of Medicine

The DOI matches its Crossref record; the references it cites are not checked yet.

Overview

Integrity signals

Registry

Crossref · 10.1056/nejmc1310845

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

The citation lists are queued

They are fetched later and appear here then.

References 7 · Cited by 30

Research works printed but not linked: 1

  1. 10.1056/NEJMoa1210951 · DOI · Paper page

Metadata

Authors
Doody, R. S., Aisen, P. S. S., & Iwatsubo, T.
Affiliations
Edith Cowan University (AU)
Venue
New England Journal of Medicine
Published
2013-10-24
Volume
369
Issue
17
Pages
1660-1661
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W1523796948
Cited by
30
References
7
Citations by year
2025: 1 · 2024: 2 · 2023: 2 · 2022: 1 · 2021: 1 · 2020: 3 · 2019: 3 · 2018: 3 · 2017: 3 · 2016: 5 · 2015: 2 · 2014: 4
Type
journal article
Language
en
Open access
closed
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • UWA Profiles and Research Repository (UWA) (submittedVersion)
  • Australasian Journal of Paramedicine (submittedVersion)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
Keywords
semagacestat, Alzheimer's disease, gamma-secretase inhibitors, amyloid-beta
MeSH terms
Alanine, Alzheimer Disease, Azepines, Female, Humans, Male, Amyloid Precursor Protein Secretases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Semagacestat for Treatment of Alzheimer's Disease. https://app.cochat.ai/papers/10.1056/nejmc1310845
The paper
Doody, R. S., Aisen, P. S. S., & Iwatsubo, T. (2013). Semagacestat for Treatment of Alzheimer's Disease. New England Journal of Medicine. https://doi.org/10.1056/nejmc1310845

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.